Co-Diagnostics (CODX) said Wednesday it closed a previously announced registered direct offering of 12.7 million common shares that were priced at $0.55 each.
The molecular diagnostics company said it plans to use the funds for working capital and general corporate purposes.
Shares of Co-Diagnostics were down over 12% in recent trading on Wednesday.
Price: 0.50, Change: -0.07, Percent Change: -12.11